BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 21947588)

  • 1. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved?
    Reynolds C; Davidson JA; Lindor NM; Glazebrook KN; Jakub JW; Degnim AC; Sandhu NP; Walsh MF; Hartmann LC; Boughey JC
    Ann Surg Oncol; 2011 Oct; 18(11):3102-9. PubMed ID: 21947588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
    Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
    Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal duct lobular units are scarce in the nipple: implications for prophylactic nipple-sparing mastectomy: terminal duct lobular units in the nipple.
    Stolier AJ; Wang J
    Ann Surg Oncol; 2008 Feb; 15(2):438-42. PubMed ID: 18004629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience.
    de Alcantara Filho P; Capko D; Barry JM; Morrow M; Pusic A; Sacchini VS
    Ann Surg Oncol; 2011 Oct; 18(11):3117-22. PubMed ID: 21847697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
    Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
    Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of terminal duct lobular units and frequency of neoplastic involvement of the nipple in mastectomy.
    Kryvenko ON; Yoon JY; Chitale DA; Lee MW
    Arch Pathol Lab Med; 2013 Jul; 137(7):955-60. PubMed ID: 23808467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens.
    Brachtel EF; Rusby JE; Michaelson JS; Chen LL; Muzikansky A; Smith BL; Koerner FC
    J Clin Oncol; 2009 Oct; 27(30):4948-54. PubMed ID: 19720921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved sub-areolar breast tissue removal in nipple-sparing mastectomy using hydrodissection.
    Folli S; Curcio A; Buggi F; Mingozzi M; Lelli D; Barbieri C; Asioli S; Nava MB; Falcini F
    Breast; 2012 Apr; 21(2):190-3. PubMed ID: 21967772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic nipple-sparing mastectomy leaves more terminal duct lobular units in situ as compared with skin-sparing mastectomy.
    van Verschuer VM; van Deurzen CH; Westenend PJ; Rothbarth J; Verhoef C; Luiten EJ; Menke-Pluijmers MB; Koppert LB
    Am J Surg Pathol; 2014 May; 38(5):706-12. PubMed ID: 24698963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nipple-sparing mastectomy: initial experience at the Memorial Sloan-Kettering Cancer Center and a comprehensive review of literature.
    Garcia-Etienne CA; Cody Iii HS; Disa JJ; Cordeiro P; Sacchini V
    Breast J; 2009; 15(4):440-9. PubMed ID: 19496781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do clinicopathological features of the cancer patient relate with nipple areolar complex necrosis in nipple-sparing mastectomy?
    Lohsiriwat V; Rotmensz N; Botteri E; Intra M; Veronesi P; Martella S; Garusi C; De Lorenzi F; Manconi A; Lomeo G; Rietjens M; Schorr M; Kneubil MC; Petit JY
    Ann Surg Oncol; 2013 Mar; 20(3):990-6. PubMed ID: 23070785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting nipple-areolar involvement using preoperative breast MRI and primary tumor characteristics.
    Steen ST; Chung AP; Han SH; Vinstein AL; Yoon JL; Giuliano AE
    Ann Surg Oncol; 2013 Feb; 20(2):633-9. PubMed ID: 22965571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nipple involvement in breast cancer: retrospective analysis of 2323 consecutive mastectomy specimens.
    Weidong Li ; Shuling Wang ; Xiaojing Guo ; Ronggang Lang ; Yu Fan ; Feng Gu ; Xinmin Zhang ; Zhengmao Zhu ; Yun Niu ; Li Fu
    Int J Surg Pathol; 2011 Jun; 19(3):328-34. PubMed ID: 21454374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of positive sub-areolar/nipple duct margins in nipple-sparing mastectomies.
    Camp MS; Coopey SB; Tang R; Colwell A; Specht M; Greenup RA; Gadd MA; Brachtel E; Austen WG; Smith BL
    Breast J; 2014; 20(4):402-7. PubMed ID: 24890641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early results of an endoscopic nipple-sparing mastectomy for breast cancer.
    Sakamoto N; Fukuma E; Higa K; Ozaki S; Sakamoto M; Abe S; Kurihara T; Tozaki M
    Ann Surg Oncol; 2009 Dec; 16(12):3406-13. PubMed ID: 19662457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total skin-sparing mastectomy in BRCA mutation carriers.
    Peled AW; Irwin CS; Hwang ES; Ewing CA; Alvarado M; Esserman LJ
    Ann Surg Oncol; 2014 Jan; 21(1):37-41. PubMed ID: 23982256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical delay of the nipple-areolar complex: a powerful technique to maximize nipple viability following nipple-sparing mastectomy.
    Jensen JA; Lin JH; Kapoor N; Giuliano AE
    Ann Surg Oncol; 2012 Oct; 19(10):3171-6. PubMed ID: 22829005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction.
    Rueth NM; McMahon M; Arrington AK; Swenson K; Leach J; Tuttle TM
    Ann Surg Oncol; 2011 Sep; 18(9):2515-20. PubMed ID: 21424371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive Nipple Margins in Nipple-Sparing Mastectomies: Rates, Management, and Oncologic Safety.
    Tang R; Coopey SB; Merrill AL; Rai U; Specht MC; Gadd MA; Colwell AS; Austen WG; Brachtel EF; Smith BL
    J Am Coll Surg; 2016 Jun; 222(6):1149-55. PubMed ID: 27118712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.